BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33322834)

  • 1. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma.
    Shah PA; Huang C; Li Q; Kazi SA; Byers LA; Wang J; Johnson FM; Frederick MJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDK1 Mediates
    Sambandam V; Frederick MJ; Shen L; Tong P; Rao X; Peng S; Singh R; Mazumdar T; Huang C; Li Q; Pickering CR; Myers JN; Wang J; Johnson FM
    Clin Cancer Res; 2019 Jun; 25(11):3329-3340. PubMed ID: 30770351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
    Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C
    Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
    Fukusumi T; Califano JA
    J Dent Res; 2018 Jun; 97(6):645-653. PubMed ID: 29489439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathways in head and neck cancer: EGFR, PI3K, and more.
    Psyrri A; Seiwert TY; Jimeno A
    Am Soc Clin Oncol Educ Book; 2013; ():246-55. PubMed ID: 23714515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
    Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC
    Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
    Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
    Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.
    Shah PA; Sambandam V; Fernandez AM; Zhao H; Mazumdar T; Shen L; Wang Q; Ahmed KM; Ghosh S; Frederick MJ; Wang J; Johnson FM
    Cancer Res; 2022 Dec; 82(23):4444-4456. PubMed ID: 36169922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
    Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
    Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis.
    Zhao YY; Yu GT; Xiao T; Hu J
    Adv Clin Exp Med; 2017 Aug; 26(5):881-887. PubMed ID: 29068587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-tethered Notch1 exhibits oncogenic property via activation of EGFR-PI3K-AKT pathway in oral squamous cell carcinoma.
    Zheng Y; Wang Z; Xiong X; Zhong Y; Zhang W; Dong Y; Li J; Zhu Z; Zhang W; Wu H; Gu W; Wu Y; Wang X; Song X
    J Cell Physiol; 2019 May; 234(5):5940-5952. PubMed ID: 30515785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
    Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.
    Agrawal N; Frederick MJ; Pickering CR; Bettegowda C; Chang K; Li RJ; Fakhry C; Xie TX; Zhang J; Wang J; Zhang N; El-Naggar AK; Jasser SA; Weinstein JN; Treviño L; Drummond JA; Muzny DM; Wu Y; Wood LD; Hruban RH; Westra WH; Koch WM; Califano JA; Gibbs RA; Sidransky D; Vogelstein B; Velculescu VE; Papadopoulos N; Wheeler DA; Kinzler KW; Myers JN
    Science; 2011 Aug; 333(6046):1154-7. PubMed ID: 21798897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma - A systematic review.
    Huang X; Leo P; Jones L; Duijf PHG; Hartel G; Kenny L; Vasani S; Punyadeera C
    Mutat Res Rev Mutat Res; 2024; 793():108477. PubMed ID: 37977279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational landscape of head and neck squamous cell carcinoma.
    Stransky N; Egloff AM; Tward AD; Kostic AD; Cibulskis K; Sivachenko A; Kryukov GV; Lawrence MS; Sougnez C; McKenna A; Shefler E; Ramos AH; Stojanov P; Carter SL; Voet D; Cortés ML; Auclair D; Berger MF; Saksena G; Guiducci C; Onofrio RC; Parkin M; Romkes M; Weissfeld JL; Seethala RR; Wang L; Rangel-Escareño C; Fernandez-Lopez JC; Hidalgo-Miranda A; Melendez-Zajgla J; Winckler W; Ardlie K; Gabriel SB; Meyerson M; Lander ES; Getz G; Golub TR; Garraway LA; Grandis JR
    Science; 2011 Aug; 333(6046):1157-60. PubMed ID: 21798893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
    Lakshmanachetty S; Balaiya V; High WA; Koster MI
    Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pairing a prognostic target with potential therapeutic strategy for head and neck cancer.
    Lek SM; Li K; Tan QX; Shannon NB; Ng WH; Hendrikson J; Tan JWS; Lim HJ; Chen Y; Koh KKN; Skanthakumar T; Kwang XL; Chong FT; Leong HS; Tay G; Putri NE; Lim TKH; Hwang JSG; Ang MK; Tan DSW; Tan NC; Tan HK; Kon OL; Soo KC; Iyer NG; Ong CJ
    Oral Oncol; 2020 Dec; 111():105035. PubMed ID: 33091845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.